Friday, March 20, 2020 12:38:51 PM
Published: March 20, 2020 at 9:50 a.m. ET
By Max A. Cherney
The SEC’s Enforcement Division has asked Cronos to preserve records related to the bulk purchase of resin and wholesale sales, according to internal communications, as company investigates revenue-recognition practices
The Securities and Exchange Commission has sent an inquiry to Cronos Group Inc., one of the largest cannabis producers in Canada, requesting the company retain records related to how it recognizes certain revenue, according to internal Cronos communications reviewed by MarketWatch.
In an email sent to employees from a company lawyer on March 10, Cronos CRON, -0.681% CRON, -1.402% instructed staff to retain certain records pertaining to a “confidential and non-public inquiry by the Securities and Exchange Commission.” The SEC Division of Enforcement has requested that the company retain and preserve all records about revenue recognition related to bulk-resin purchases and wholesale sales of biomass or other products, according to the email and an attached document. Bulk resin is a type of cannabis concentrate, and biomass is marijuana from which companies typically extract oil for vape products or edibles.
Cronos and the SEC declined to comment.
Cronos — a Canadian licensed pot producer backed by a $1.8 billion investment from tobacco company Altria Group Inc. MO, -4.636% — said in an SEC filing on March 2 that it was conducting an internal review into its accounting practices surrounding purchases of marijuana extracts and wholesale revenue. Cronos disclosed Tuesday that as a result of its review it would have to reissue three quarters of financial statements for 2019, and will report C$2.5 million in reduced revenue for the first quarter and C$5.1 million for the third quarter. The company also disclosed that it would likely report “one or more” material weaknesses in its internal controls related to financial reporting.
See also: Cronos paid $300 million for a small CBD company, and CEO’s private-equity firm stands to collect $120 million of it
Cronos instructed staff not to discuss the inquiry and to take immediate steps to preserve records dating back to July 1, 2018, the document says. The document instructs Cronos employees to preserve records related to specific transactions, negotiations and other dealings with MediPharm Labs Corp. LABS, 11.321%, a Canadian extraction business; TerrAscend Corp. TER, +11.39%, which operates dispensaries in California and elsewhere; and Canadian licensed producers Heritage Cannabis Holdings Corp. CANN, 4.000% and 48North Cannabis Corp. NRTH, -4.54%, along with subsidiaries of the companies.
48North, Heritage Cannabis and MediPharm declined to comment. TerrAscend did not respond to a request for comment.
Altria paid $1.8 billion to acquire a 45% stake in Cronos in December 2018, along with warrants that, if exercised, would raise that stake to 55%. The deal gave the maker of Marlboro and other tobacco brands an exclusive partnership in the cannabis sector just months after Canada fully legalized weed. Altria did not respond to a request for comment.
Source: https://finance.yahoo.com/m/79c6bf08-55e7-3a38-aff9-a5b927cbb737/exclusive-pot-company-cronos.html
**DISCLOSURE** My posts express my sole opinion. They are not investment advice nor a recommendation regarding any course of action. My opinions are subject to change without notice. Assess investments according to your personal financial circumstances.
Recent CRON News
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/15/2024 09:02:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 09:09:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 09:06:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2024 09:05:10 PM
- U.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25% • IH Market News • 05/09/2024 11:47:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:32:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:31:22 AM
- Cronos Group Reports 2024 First Quarter Results • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- Cronos Enters United Kingdom Cannabis Market • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Cronos Group Inc. to Hold Virtual 2024 Annual Meeting of Shareholders • GlobeNewswire Inc. • 04/26/2024 08:45:00 PM
- Cronos Group Inc. to Hold 2024 First Quarter Earnings Conference Call on May 9, 2024 • GlobeNewswire Inc. • 04/25/2024 08:15:00 PM
- Marijuana Stocks Up After Banking Reform Progress • IH Market News • 04/09/2024 10:05:42 AM
- Cronos Launches Lord Jones® Chocolate Fusions • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Cronos Group Inc. to Speak at the 36th Annual Roth Conference • GlobeNewswire Inc. • 03/12/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:24:53 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/05/2024 10:21:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:17:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:15:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:13:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:09:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 09:16:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 01:06:27 PM
- Cronos Group Reports 2023 Fourth Quarter and Full-Year Results¹ • GlobeNewswire Inc. • 02/29/2024 01:05:00 PM
- U.S. Futures Dip as PCE Data Looms; Modest Gains for WTI and Brent Crude in April Contracts • IH Market News • 02/29/2024 11:13:07 AM
- Cronos Group Inc. to Hold 2023 Fourth Quarter and Full-Year Earnings Conference Call on February 29, 2024 • GlobeNewswire Inc. • 02/14/2024 09:15:00 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM